Table 5.

Mean ± SD PSA values before (M-14 to M-1), during (M0–M6), and after (M8) treatment for both randomized groups

Time, moPlacebo (n)Sulphoraphane (n)
M-140.4 ± 0.382 (40)0.38 ± 0.423 (38)
M-60.55 ± 0.46 (40)0.54 ± 0.549 (38)
M-10.74 ± 0.636 (40)0.73 ± 0.637 (38)
M00.78 ± 0.683 (40)0.74 ± 0.644 (38)
M10.86 ± 0.799 (40)0.75 ± 0.661 (38)
M31.03 ± 1.185 (40)0.86 ± 0.73 (36)
M61.41 ± 1.897 (39)0.87 ± 0.638 (36)
M81.57 ± 2.411 (37)0.93 ± 0.726 (35)

NOTE: n, number of patients.